COSMOS HEALTH NEW DL-01 (F:V67A) — Market Cap & Net Worth
Market Cap & Net Worth: COSMOS HEALTH NEW DL-01 (V67A)
COSMOS HEALTH NEW DL-01 (F:V67A) has a market capitalization of $12.88 Million (€11.02 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #26231 globally and #2260 in its home market, demonstrating a 3.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COSMOS HEALTH NEW DL-01's stock price €0.32 by its total outstanding shares 34919920 (34.92 Million).
COSMOS HEALTH NEW DL-01 Market Cap History: 2022 to 2026
COSMOS HEALTH NEW DL-01's market capitalization history from 2022 to 2026. Data shows change from $171.96 Million to $12.88 Million (-64.70% CAGR).
COSMOS HEALTH NEW DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COSMOS HEALTH NEW DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of V67A by Market Capitalization
Companies near COSMOS HEALTH NEW DL-01 in the global market cap rankings as of May 5, 2026.
Key companies related to COSMOS HEALTH NEW DL-01 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $98.95 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #439 globally with a market cap of $59.07 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #561 globally with a market cap of $46.37 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1108 globally with a market cap of $23.12 Billion USD ( AU$32.67 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $98.95 Billion | $807.85 |
| #439 | Cencora Inc. | NYSE:COR | $59.07 Billion | $303.66 |
| #561 | Cardinal Health Inc | NYSE:CAH | $46.37 Billion | $197.06 |
| #1108 | Sigma Healthcare Ltd | AU:SIG | $23.12 Billion | AU$2.83 |
COSMOS HEALTH NEW DL-01 Historical Marketcap From 2022 to 2026
Between 2022 and today, COSMOS HEALTH NEW DL-01's market cap moved from $171.96 Million to $ 12.88 Million, with a yearly change of -64.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €12.88 Million | -23.21% |
| 2025 | €16.78 Million | -35.73% |
| 2024 | €26.11 Million | -51.92% |
| 2023 | €54.30 Million | -68.42% |
| 2022 | €171.96 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of COSMOS HEALTH NEW DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.88 Million USD |
| MoneyControl | $12.88 Million USD |
| MarketWatch | $12.88 Million USD |
| marketcap.company | $12.88 Million USD |
| Reuters | $12.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more